Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction
AbstractAims. Glucagon-like peptide 1 (GLP-1) is a gut incretin hormone inducing post-prandial insulin secretion. Glucagon-like peptide 1 levels were recently
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2020
|
| In: |
European heart journal
Year: 2019, Jahrgang: 41, Heft: 7, Pages: 882-889 |
| ISSN: | 1522-9645 |
| DOI: | 10.1093/eurheartj/ehz728 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehz728 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/article/41/7/882/5588525 |
| Verfasserangaben: | Florian Kahles, Marcia V. Rückbeil, Robert W. Mertens, Ann C. Foldenauer, Maria C. Arrivas, Julia Moellmann, Corinna Lebherz, Moritz Biener, Evangelos Giannitsis, Hugo A. Katus, Nikolaus Marx, and Michael Lehrke |
| Zusammenfassung: | AbstractAims. Glucagon-like peptide 1 (GLP-1) is a gut incretin hormone inducing post-prandial insulin secretion. Glucagon-like peptide 1 levels were recently |
|---|---|
| Beschreibung: | Online publish-ahead-of-print: 16 October 2019 Gesehen am 31.03.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1522-9645 |
| DOI: | 10.1093/eurheartj/ehz728 |